Hence, we speculated that mefloquine combined with other chemotherapeutic agents might be promising therapeutic regimens via targeting the ALKBH5‐RAB5A signal axis and could better improve the prognosis of CRC. Here, RAB5A is linked to colorectal carcinoma.